Q&A with FDA
af U.S. Food and Drug Administration, Center for Drug Evaluation and Research
Recognizing and Reporting Potentially False or Misleading…
Om denne podcast
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
Episoder
- Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray · 14 min.Q&A with FDA: Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray
- Understanding Drug Recalls with Dr. Ileana Elder · 25 min.In this episode of the Q&A with FDA podcast, learn about Understanding Drug Recalls with Dr. Ileana Elder in the Office of Compliance.
- Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim · 24 min.In this episode of the Q&A with FDA podcast, learn about Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim from FDA’s Office of Generic Drugs.
- Real-World Data and Evidence Generation with Dr. Hilary Marston · 21 min.In this episode of the Q&A with FDA podcast, learn about real world evidence, real world data, and how FDA continues to advance clinical trials and promote reliable evidence to…
- The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad · 24 min.Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.
- Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim · 12 min.Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.
- The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein · 16 min.The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
- Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng · 15 min.Listen to our latest podcast series, Q&A with FDA, on Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng.
- FDA’s Regulation of Dietary Supplements with Dr. Cara Welch · 13 min.Listen to our latest podcast series, Q&A with FDA - FDA’s Regulation of Dietary Supplements featuring Dr. Cara Welch.
- A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska · 9 min.Listen to our latest podcast series, Q&A with FDA, on A Step Forward in the Treatment of Opioid and Alcohol Dependence featuring Dr. Iilun Murphy and Dr. Marta Sokolowska.
- Navigating the World of Online Pharmacies with CDR Lysette Deshields · 9 min.Navigating the World of Online Pharmacies with CDR Lysette Deshields
- CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito · 20 min.Listen to our latest podcast series, Q&A with FDA
- FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska · 12 min.FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska
- Drug Shortages with CDR Emily Thakur · 11 min.In this podcast series, we answer some of the most frequently asked questions we’ve received from the public.
- Expanded Access with Dr. Jacqueline Corrigan-Curay · 13 min.Expanded Access with Dr. Jacqueline Corrigan-Curay
- FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska · 7 min.FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska
- Conversation on Paxlovid · 15 min.In today’s episode, we’ll be discussing Paxlovid, which is now widely available in community pharmacies.








